AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Pipeline Embolization for Intracranial Aneurysms

Recruitingn/aAges 22 Years - 75 YearsAllZhujiang Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study collected the clinical, laboratory, and imaging data from patients with intracranial aneurysms, who underwent Pipeline implantation. The purpose of this study is to observe the safety, effcacy, and haemodynamics after Pipeline embolization.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria: 1. Aged 22 to 75 years old, male or non-pregnant female; 2. UIA was diagnosed by CTA, MRA, or DSA; 3. The size of aneurysms is between 3 to 25mm; 4. Understands the nature of the procedure and provision of written informed consent; 5. Indications for FD implantation with or without adjunctive coiling; 6. Is willing to return to the investigational site for follow-up according to our protocol. Exclusion criteria: 1. With contraindications to flow-diversion treatment or known allergy to cobalt-chromium alloy or contrast medium; 2. Pregnancy or lactation; 3. Coexist with other vascular lesions (coronary artery disease, abdominal aortic aneurysm, severe intracranial artery stenosis, arteriovenous malformation, dural arteriovenous fistula, Moyamoya disease, etc.); 4. Parent vessel with a diameter \<2.0 mm or โ‰ฅ5.0 mm.; 5. Unwilling to be followed up or likely to have poor treatment compliance; 6. Life expectancy less than 3 years; 7. Inability to receive anti-platelet or anticoagulant medication; 8. Severe neurological deficit that renders the patient unable to live independently (modified Rankin score โ‰ฅ4); 9. Enrollment in another trial or other situations that the researcher deems unsuitable for inclusion in the study.
๐Ÿ’Š

What it tests

  • Pipeline embolization device with or without shield technique
๐Ÿ“

Where

1 site
Zhujiang hospital
Guangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy